Clinical Trial Update: MAP Study: Methotrexate and Adalimumab in Psoriasis [Phase 2, Phase 3]

View source ↗

Summary

A trial update for MAP Study investigating methotrexate and adalimumab in psoriasis across Phase 2 and Phase 3, with completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Jeffrey J Crowley MD | Conditions: Psoriasis | Phase 2, Phase 3 | Status: COMPLETED